StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Biogen (BIIB) Reports Interferon Beta Treatments, Including PLEGRIDY (peginterferon beta-1a) & AVONEX (interferon beta-1a), Positive Receive Positive CHMP Opinion
September 23, 2019 5:54 AM
Biogen Inc. (NASDAQ: BIIB) today announced that the Committee for Medicinal Products for Human Use (CHMP), part of the of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Management Comments
Next Articles
Interferon Beta Treatments, Including PLEGRIDY® (peginterferon beta-1a) and AVONEX® (interferon beta-1a), Receive Positive CHMP Opinion for Use During Pregnancy and Breastfeeding
September 23, 2019 3:00 AM